The Asia Pacific Protein Expression Market would witness market growth of 10.9% CAGR during the forecast period (2022-2028).
Major applications of protein expression can be found in research, industry, pharmaceuticals, and other fields. Therapeutic proteins are frequently used to treat a variety of chronic conditions, including diabetes, cancer, and multiple sclerosis. These proteins include peptide hormones, vaccinations, therapeutic enzymes, monoclonal antibodies, antibodies, blood factors, and cytokines. Such proteins have improved biologics production quality, precision, and efficiency. Today, one may find recombinant proteins made using DNA technology in almost every western drugstore, doctor's or veterinarian's office, medical testing facility, and biological research facility.
Researchers are being prompted to carry out investigations due to the high capability of genomic studies. Investment in genomic research has increased significantly since the conclusion of the Human Genome Project. Furthermore, it is hoped that initiatives like the Precision Medicine Initiative and improvements in companion diagnostic studies would hasten the implementation of expression analysis. The encouraging findings of these studies show the possibility of using genetics to enhance healthcare facilities. RNA-Sequencing, PCR variations, data interpretation, and analysis algorithms, as well as other high-throughput technologies, have rapidly advanced, giving researchers highly effective tools for expression analysis.
In the Asia-Pacific, consumers are increasingly able to buy cutting-edge therapies for chronic ailments as a result of rising disposable income. Additionally, there is a rise in public awareness of early disease identification, which is also assisting in the expansion of protein expression techniques. China has emerged as the center of development and research over the past ten years. The field of protein expression offers a vast area for research, and the nation is particularly active in this sector.
The China market dominated the Asia Pacific Protein Expression Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $367.8 Million by 2028. The Japan market is anticipated to grow at a CAGR of 10.2% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 11.6% during (2022 - 2028).
Based on System, the market is segmented into Prokaryotic, Mammalian Cell, Insect Cell, Yeast, and Others. Based on Product, the market is segmented into Reagents, Competent Cells, Instruments, Services, and Others. Based on Application, the market is segmented into Therapeutic, Industrial, Research. Based on End-user, the market is segmented into Pharmaceutical & Biotechnological Companies, Academic Research, Contract Research Organizations, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Protein Expression Market is Projected to reach USD 4.9 Billion by 2028, at a CAGR of 10.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck Group, New England BioLabs, Inc., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and LGC Biosearch Technologies.
By System
By Product
By Application
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 